Posttransplantation de novo tumors in liver allograft recipients

Liver Transplantation and Surgery

Volumn 2, Issue 1, 1996, Pages 52-59

  Penn, I ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; PREDNISONE; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ALLOGRAFT; ARTICLE; CHILD; FEMALE; GRAFT REJECTION; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY TUMOR; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN CANCER; TUMOR; ULCERATIVE COLITIS; UTERINE CERVIX CARCINOMA; VULVA CARCINOMA;

EID: 0030051728     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500020109     Document Type: Article

References (40)

1. 1 Penn I. Why do immunosuppressed patients develop cancer? In: Pimentel E, ed. CRC critical reviews in oncogenesis. Vol 1. Boca Raton: CRC, 1989: 27–52.
2. 2 Penn I. The changing patterns of posttransplant malignancies. Transplant Proc 1991 ; 23: 1101–1103.
3. 3 Penn I. Immunosuppression—A contributory factor in lymphoma formation. Clin Transplant 1992 ; 6: 214–219.
4. 4 Penn I. Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 1993 ; 12: 5328–5336.
5. 5 Blohme I, Brynger H. Malignant disease in renal transplant patients. Transplantation 1985 ; 39: 23–35.
6. 6 Kinlen LJ. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment, Am J Med 1985 ; 78: (supl 1A) 44–49.
7. 7 Sheil AGR, Disney APS, Mathew TH, Amiss N, Excell N. Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CYA) or AZA/CYA. Transplant Proc 1991 ; 23: 1111–1112.
8. 8 Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, et al. Reversibility of lymphomas and lymph‐oproliferative lesions developing under cyclosporinesteroid therapy. Lancet 1984 ; 1: 583–587.
9. 9 Penn I. Posttransplant de novo malignancies. In: Busuttil RW, Klintmalm GB, eds. Transplantation of the liver. Philadelphia: Saunders, in press.
10. 10 Polson RJ, Neuberger J, Forman D, Calne R, Williams R. De novo malignancies after liver transplantation. Transplant Proc 1988 ; 20: 94–97.
11. 11 Levy M, Backman L, Husberg B, Goldstein R, McMillan R, Gibbs J, et al. De novo malignancy following liver transplantation: A single‐center study. Transplant Proc 1993 ; 25: 1397–1399.
12. 12 Nalesnik MA, Locker J, Jaffe R, Reyes J, Cooper M, Fung J, et al. Experience with posttransplant lymphopro‐liferative disorders in solid organ transplant recipients. Clin Transplant 1992 ; 6: 249–252.
13. 13 Danhaive O, Ninane J, Sokal E, Latinne D, Phillipe M, Gosseye S, et al. Hepatic localization of a fibrosarcoma in a child with a liver transplant. J Ped 1992 ; 120: 434–437.
14. 14 Doyle H, Tzakis AG, Yunis E, Starzl TE. Smooth muscle tumor arising de novo in a liver allograft: A case report. Clin Transplant 1991 ; 5: 60–62.
15. 15 Penn I. De novo malignancy in pediatric organ transplant recipients. J Pediatr Surg 1994 ; 29: 221–228.
16. 16 Sokal EM, Caragiozoglou T, Lamy M, Reding R, Otte JB. Epstein‐Barr virus serology and Epstein‐Barr virus associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation 1993 ; 56: 1394–1398.
17. 17 Renard TH, Andrews WS, Foster ME. Relationship between OKT3 administration, EBV conversion, and the lymphoproliferative syndrome in pediatric liver transplant recipients. Transplant Proc 1991 ; 23: 1473–1476.
18. 18 Joseph G, Barker RL, Yuan B, Martin A, Madeiros J, Peiper SC. Posttransplantation plasma cell dyscrasias. Cancer 1994 ; 74: 1959–1964.
19. 19 Schemankewitz E, Hammami A, Stahl R, Henderson JM, Check IJ. Multiple extramedullary plasmacytomas following orthotopic liver transplantation in a patient on cyclosporine therapy. Transplantation 1990 ; 49: 1019–1022.
20. 20 Nalesnik MA, Randhawa P, Demetris AJ, Casavilla A, Fung JJ, Locker J. Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient. Cancer 1993 ; 72: 2568–2573.
21. 21 Cherqui D, Duvoux C, Plassa F, Gaulard P, Julien M, Fabniez PL, et al. Lymphoproliferative disorder of donor origin in a liver transplant recipient: Complete remission after drastic reduction of immunosuppression without graft loss. Transplantation 1993 ; 56: 1023–6.
22. 22 Honda H, Franken EA Jr, Barloon TJ, Smith JL. Hepatic lymphoma in cyclosporine‐treated transplant recipients: Sonographic and CT findings. Amer J Roentgenol 1989 ; 152: 501–503.
23. 23 Spiro IJ, Yandell DW, Li C, Saini S, Ferry J, Powelson J, et al. Brief report: Lymphoma of donor origin occurring in the porta hepatis of a transplanted liver. New Engl J Med 1993 ; 329: 27–29.
24. 24 Moody AR, Wilson SR, Greig PD. Non‐Hodgkin lymphoma in the porta hepatis after orthotopic liver transplantation: Sonographic findings. Radiology 1992 ; 182: 867–870.
25. 25 Lee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, et al. The association of Epstein‐Barr virus with smooth‐muscle tumors occurring after organ transplantation. New Engl J Med 1995 ; 332: 19–25.
26. 26 Timmons CF, Dawson DB, Richards S, Andrews WA, Katz JA. Epstein‐Barr virus associated leiomyosarcomas in liver transplant recipients: Origin from either donor or recipient tissue. Cancer, in press.
27. 27 Van Hoeven KH, Factor SM, Kress Y, Woodruff JM. Visceral myogenic tumors: a manifestation of HIV infection in children. Am J Surg Path 1993 ; 17: 1176–1181.
28. 28 Mueller BU, Butler KM, Higham MC, Husson RN, Montrella KA, Pizzo PA, et al. Smooth muscle tumors in children with human immunodeficiency virus infection. Pediatrics 1992 ; 90: 460–463.
29. 29 McLain KL, Leach CT, Jenson HB, Joshi VV, Pollock BH, Parmley RT, et al. Association of Epstein‐Barr virus with leiomyosarcomas in young people with AIDS. New Engl J Med 1995 ; 332: 12–18.
30. 30 Penn I. Primary kidney tumors before and after renal transplantation. Transplantation 1995 ; 59: 480–485.
31. 31 Zorn BH, Taylor RJ, Wood RP, Stratta RJ, Shaw BW. Renal cell carcinoma in a liver transplant recipient. Transplant Proc 1991 ; 23: 2287–2289.
32. 32 Spiro HM. Clinical Gastroenterology. 2nd Ed. New York: Macmillan, 1977: 805–811.
33. 33 Bleday R, Lee E, Jesserun J, Heine J, Wong WD. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 1993 ; 36: 908–912.
34. 34 Higashi H, Yanaga K, Marsh JW, Tzakis A, Kakizoe S, Starzl TE. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology 1990 ; 11: 477–480.
35. 35 Schröter GPJ, Weil R III, Penn I, Speers WC, Waddell WR. Hepatocellular carcinoma associated with chronic hepatitis B virus infection after kidney transplantation (Letter). Lancet 1982 ; 2: 381–382.
36. 36 Wee A, Ludwig J, Coffey RJ, Larusso NF, Weisner RH. Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol 1985 ; 16: 719–726.
37. 37 Koneru B. Liver transplantation for malignant tumors. Surg Rounds 1989 ; 12: 23–28.
38. 38 Delcore R, Eisenach JB, Payne KM, Bhatia P, Forster J. Risk of occult carcinomas in patients undergoing orthotopic liver transplantation for end‐stage liver disease secondary to primary sclerosing cholangitis. Transplant Proc 1993 ; 25: 1883–4.
39. 39 Miros M, Kerlin P, Walker N, Harper J, Lynch S, Strong R. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gut 1991 ; 32: 1369–1373.
40. 40 Herbener T, Zajko AB, Koneru B, Bron KM, Campbell WL. Recurrent cholangiocarcinoma in the biliary tree after liver transplantation. Radiology 1988 ; 169: 641–642.